Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy

Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy

Abstract Background The value of Epstein–Barr virus (EBV) DNA assay during posttreatment follow-up of the patients with nasopharyngeal carcinoma (NPC) presenting with different pretreatment plasma EBV DNA levels remains unclear. In the present study, we aimed to evaluate the prognostic value of plas...

Full description

Bibliographic Details
Main Authors: Wen-Fei Li, Yuan Zhang, Xiao-Bin Huang, Xiao-Jing Du, Ling-Long Tang, Lei Chen, Hao Peng, Rui Guo, Ying Sun, Jun Ma
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Chinese Journal of Cancer
Subjects:
Nasopharyngeal carcinoma
Epstein–Barr virus DNA
Follow-up
Tumor recurrence
Online Access:http://link.springer.com/article/10.1186/s40880-017-0256-x

Internet

http://link.springer.com/article/10.1186/s40880-017-0256-x

Similar Items